Trial Profile
A trial evaluating the efficacy, endoscopic responses and predictors of efficacy of adalimumab in patients with Crohn's disease in clinical practice
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 04 Feb 2016
Price :
$35
*
At a glance
- Drugs Adalimumab (Primary)
- Indications Crohn's disease
- Focus Adverse reactions; Therapeutic Use
- 04 Feb 2016 New trial record